|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$412,354
|
$288,648
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-06S1
|
$74,858
|
$2,246
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-06
|
$1,560,000
|
$46,800
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
5R01CA044722-24
|
$216,873
|
$108,437
|
STUDZINSKI, GEORGE
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
Vanderbilt Clinical Oncology Research Career Development Award
|
5K12CA090625-14
|
$1,007,108
|
$100,711
|
HANDE, KENNETH
|
VANDERBILT UNIVERSITY
|
|
Validation of PROMIS Measures in Children with Brain Tumors
|
5R01CA174452-03
|
$290,100
|
$290,100
|
LAI, JIN-SHEI
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Validation and Development of WEE1 as a therapeutic target in AML
|
5R01CA172385-02
|
$305,619
|
$152,810
|
PORTER, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
Validating the prognostic value of EGFR768 in neuroblastoma
|
1R21CA187554-01
|
$169,711
|
$169,711
|
CHAN, EDWARD
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Validating Syk as a Target for AML Therapy
|
2R01CA140292-06
|
$387,775
|
$387,775
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S1
|
$74,856
|
$1,497
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S2
|
$122,401
|
$2,448
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-40S3
|
$150,000
|
$3,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-40
|
$4,421,130
|
$88,423
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
1R01CA175026-01A1
|
$405,847
|
$405,847
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using mouse models to understand retinoblastoma initiation and progression
|
5R01CA148867-06
|
$386,570
|
$386,570
|
MACPHERSON, DAVID
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$25,483
|
$7,645
|
Merlino, Glenn
|
CCR (NCI)
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S1
|
$75,000
|
$12,750
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S2
|
$4,154
|
$706
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S3
|
$12,487
|
$2,123
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S4
|
$126,993
|
$21,589
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-39
|
$6,071,261
|
$1,032,114
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unmetabolized folic acid and retinoblastoma.
|
5R21CA167833-02
|
$171,403
|
$171,403
|
ORJUELA, MANUELA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-28S1
|
$48,718
|
$487
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-28
|
$1,485,000
|
$14,850
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Unleashing the Efficacy of PI3K/AKT/mTOR Pathway Inhibitors in B-ALL
|
1F32CA189629-01
|
$53,282
|
$53,282
|
VO, THANH-TRANG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
University of Rochester Cancer Center CCOP Research Base
|
3U10CA037420-29S1
|
$365,619
|
$3,656
|
MORROW, GARY
|
UNIVERSITY OF ROCHESTER
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S1
|
$75,000
|
$23,250
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S2
|
$113,250
|
$35,108
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S3
|
$125,000
|
$38,750
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S4
|
$50,000
|
$15,500
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-10
|
$1,876,081
|
$581,585
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S1
|
$74,531
|
$1,491
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S2
|
$49,999
|
$1,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-26S3
|
$310,728
|
$6,215
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-26
|
$5,914,688
|
$118,294
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-02S1
|
$75,000
|
$750
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-02S2
|
$150,000
|
$1,500
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
5P30CA177558-02
|
$1,500,000
|
$15,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
Uncovering the anti-apoptotic mechanism of mutated ALK in neuroblastoma
|
1F32CA183566-01A1
|
$51,530
|
$51,530
|
MOORE, NATHAN
|
DANA-FARBER CANCER INST
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-05
|
$327,998
|
$327,998
|
BAKER, SHARYN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Tumor-produced TNF alpha as an inducer of immune resistance and tumor survival
|
5R01CA136663-05
|
$320,189
|
$320,189
|
LEVITSKAIA, ELENA
|
JOHNS HOPKINS UNIVERSITY
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$358,240
|
$358,240
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor and Metastasis Biology
|
ZIA BC 010566
|
$412,923
|
$412,923
|
Helman, Lee
|
CCR (NCI)
|
|
Tsc1/mTOR axis in immune homeostasis and tumorigenesis
|
1R01CA176624-01A1
|
$369,350
|
$369,350
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
|
5R01CA154998-04
|
$286,395
|
$143,198
|
FARRAR, MICHAEL
|
UNIVERSITY OF MINNESOTA
|
|
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
|
5R01CA178765-02
|
$548,492
|
$548,492
|
ROEDER, ROBERT
|
ROCKEFELLER UNIVERSITY
|
|
Training Program in Pediatric Cancer Epidemiology and Control
|
5R25CA160078-04
|
$516,699
|
$516,699
|
SPITZ, MARGARET
|
BAYLOR COLLEGE OF MEDICINE
|
|
Training of Physician Scientists in Cancer Research
|
5T32CA009659-20
|
$131,677
|
$131,677
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Toxicity Monitoring on Phase III Trials with Administrative Data
|
5R01CA165277-03
|
$397,781
|
$397,781
|
APLENC, RICHARD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$531,130
|
$26,556
|
Hewitt, Stephen
|
CCR (NCI)
|
Total relevant funding to Childhood Cancers for this search: $203,716,485
|